Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Tekla Healthcare Opportunities Fund
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Tekla Healthcare Opportunities Fund since year 2005.
Table 2 shows the detailed insider transactions of Tekla Healthcare Opportunities Fund since 2005.
The reporting company's ticker symbol is THQ. The reporting company's CIK number is 1604522.
The total value of stock buying since 2005 is $470,572.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2018-10-17||Omstead Daniel R (President)||Buy||5,902||18.19||107,375|
|2018-10-11||Omstead Daniel R (President)||Buy||5,500||17.59||96,761|
|2018-10-10||Omstead Daniel R (President)||Buy||5,500||18.27||100,468|
|2018-01-25||Kent Thomas M (Director)||Buy||1,400||18.50||25,902|
|2014-12-03||Stebbins Lucinda H (Director)||Buy||1,000||20.07||20,066|
|2014-07-28||Omstead Daniel R (President)||Buy||1,000||20.00||20,000|
|2014-07-28||Bonney Michael W (Director)||Buy||5,000||20.00||100,000|
Insider trading activities including stock purchases, stock sales, and option exercises of THQ listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Tekla Healthcare Opportunities Fund (symbol THQ, CIK number 1604522) see the Securities and Exchange Commission (SEC) website.